Structural Rationalization of IPMK Inhibitor Potency
Inositol polyphosphate multikinase (IPMK) is a kinase linked to several cancers; recent development of a large panel of ATP-competitive inhibitors has reinvigorated enthusiasm for targeting IPMK. However, the structural basis for how these inhibitors achieve high potency is unknown. Herein, we report 14 novel cocrystal structures (1.7-2.0 resolution) of human IPMK kinase domain with these inhibitors. We also apply a radiolabeled assay and isothermal titration calorimetry that permit high-confidence IC<sub>50</sub> and <i>K</i><sub>D</sub> value determinations. The structures reveal a pocket in the ATP-binding site engaged by the most potent inhibitors. Two ordered waters also participate in hydrogen-bonding networks associated with the most potent inhibitors. In addition to providing the molecular basis for observed increases in potency and selectivity, the data presented here provide a toolbelt of 14 novel inhibitor-bound structures of human IPMK that can serve as a reference for all future IPMK structure-based inhibitor development efforts.
Authors
- Stephen B. Shears (ORCID: https://orcid.org/0000-0001-7309-8916)
- Huanchen Wang (ORCID: https://orcid.org/0000-0003-2701-7155)
- Raymond D. Blind (ORCID: https://orcid.org/0000-0002-1358-6309)
Institutions
- Vanderbilt University (US)
- Diabetes Australia (AU)
- National Institute of Environmental Health Sciences (US)
- Pharmacology Research Institute (US)
- Institute of Pharmacology (CZ)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Medicinal Chemistry
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1021/acs.jmedchem.5c02314
- Citations
- 1
- Primary Topic
- Protein Kinase Regulation and GTPase Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.81